JCI vs REPL · P/E 44, rev $23.60B vs $825.7M cap
Johnson Controls International PLC (JCI) versus Replimune Group Inc (REPL) — a side-by-side from cached financials, not a winner call.
Johnson Controls International PLC (JCI) is a building products & equipment company listed on NYSE.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Latest reported JCI revenue for 2025-09-30 was $23.60B. Net income was $3.51B. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
REPL does not have a complete income-statement cache yet.
JCI currently screens at market cap $87.62B and trailing P/E 43.9. REPL currently screens at market cap $825.7M.
Not investment advice. Open the JCI and REPL stock pages for the full models.
Not investment advice.